| Sample | Title | Value | Rank |
|---|
| GSM132917 | SKI-DLCL cells_untreated_24h_1rpt | 5335.3 | 100 |
| GSM132918 | SKI-DLCL cells_untreated_24h_2rpt | 5518.2 | 100 |
| GSM132920 | SKI-DLCL cells_untreated_24h_rpt3 | 5910.3 | 100 |
| GSM132941 | SKI-DLCL cells_Aplidin 3nM_24h_rpt1 | 6566.7 | 100 |
| GSM132944 | SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2 | 7092.3 | 100 |
| GSM132947 | SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3 | 6643.6 | 100 |
| GSM132949 | SKI-DLCL cells_AraC 20nM_24h_rpt1 | 5952 | 100 |
| GSM132950 | SKI-DLCL cells_AraC 20nM_24h_rpt2 | 5515.7 | 100 |
| GSM132953 | SKI-DLCL cells_AraC 20nM_24h_rpt3 | 4676.2 | 100 |
| GSM132955 | SKI-DLCL cells_Aplidin 1.5nM AraC 5nM_24h_rpt1 | 5883.5 | 100 |
| GSM132956 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5nM_24h_rpt2 | 5449.8 | 100 |
| GSM132960 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5.0 nM_24h_rpt3 | 5865 | 100 |
| GSM132760 | SKI-DLCL_tumor_untreated animals | 5647.4 | 100 |
| GSM132916 | SKI-DLCL_tumor_animals treated with 1mg/kg Aplidin_50mg/kg AraC | 6407.6 | 99 |